GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Fortress Biotech Inc.
Fortress Biotech is a unique biopharmaceutical company with a diversified portfolio. Its stock price reflects the successes and failures of its numerous subsidiaries, which reduces the risk of a single drug failing, but complicates analysis.
Share prices of companies in the market segment - Miscellaneous oncology
Fortress Biotech is a biopharmaceutical company developing a portfolio of several assets at various stages of development in partnership with other companies. We classify it as "Diverse Oncology." The chart below shows the dynamics of this diversified segment.
Broad Market Index - GURU.Markets
Fortress Biotech is a diversified biotech company that invests in and develops a portfolio of promising drug candidates. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Fortress's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
FBIO - Daily change in the company's share price Fortress Biotech Inc.
Fortress Biotech, Inc.'s daily price change reflects the aggregate volatility of its biotech portfolio. This metric demonstrates sensitivity to multiple research findings, making it an important element for analyzing diversified biotech companies.
Daily change in the price of a set of shares in a market segment - Miscellaneous oncology
Fortress Biotech, Inc. is a diversified biotech company. This chart highlights the sector's high volatility. Comparing it to FBIO, a portfolio of several companies, helps assess how diversification impacts its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Fortress Biotech is an incubator that develops and finances a portfolio of several biotech startups. Its shares represent a diversified biotech bet. Their performance is the result of a cumulative impact of news across various projects, creating a complex volatility landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Fortress Biotech Inc.
The dynamics of Fortress Biotech, Inc. tell the story of its unique business model for developing and commercializing biotech assets. Its market capitalization over the past 12 months reflects the cumulative progress of its subsidiaries, each developing its own drugs in various medical fields.
Annual dynamics of market capitalization of the market segment - Miscellaneous oncology
Fortress Biotech, Inc. is a unique company that not only develops its own drugs but also invests in other biotech companies. The chart shows how its diversified yet complex portfolio and the success of its partner companies influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Fortress, with its biotech startup incubator model, offers investors a diversified exposure to the sector. Its revenue isn't dependent on the success of a single company. Fortress's stock performance is a story about how to participate in biotech growth while mitigating the risks associated with the failure of individual clinical trials.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Fortress Biotech Inc.
Fortress Biotech is a diversified biotech company with a broad development pipeline. Its monthly performance reflects the combined impact of news across its many subsidiaries and clinical programs. Success in any one of these can significantly impact the holding's overall valuation.
Monthly dynamics of market capitalization of the market segment - Miscellaneous oncology
Fortress Biotech is a biotech company with a diversified business model. It acquires, develops, and commercializes promising drugs, often creating subsidiaries for this purpose. The chart below illustrates the dynamics of the biotech sector, where Fortress offers a model similar to a venture capital fund.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Fortress Biotech is a biotech holding company with a diversified portfolio of drugs and companies. This structure may mitigate the risks associated with the failure of a single trial. However, the stock still moves primarily on news from its portfolio companies, rather than the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Fortress Biotech Inc.
Fortress Biotech, a unique company with a diversified portfolio of biotech assets, has been exhibiting complex weekly performance. Its stock fluctuations reflect news from its many subsidiaries developing cancer drugs, creating a complex but breakthrough-sensitive profile.
Weekly dynamics of market capitalization of the market segment - Miscellaneous oncology
Fortress Biotech operates as an incubator for various oncology startups. The investor's goal is to understand whether diversification protects the company from common risks. The chart below helps compare its weekly performance with the sector and assess the success of its unique business model.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Fortress Biotech operates as an incubator for biotech startups. Its success depends on the research results of its portfolio companies. The chart will help us understand whether Fortress Biotech moves independently of the market due to the specific nature of its assets, or whether its diversified model follows the general sentiment in the sector.
Market capitalization of the company, segment and market as a whole
FBIO - Market capitalization of the company Fortress Biotech Inc.
Fortress Biotech's chart is a financial incubator of biotech hopes. Its market cap reflects not just one drug, but investors' faith in its unique model for acquiring and developing promising oncology developments. The chart's performance is a holistic assessment of the risks and potential successes of its entire diversified portfolio.
FBIO - Share of the company's market capitalization Fortress Biotech Inc. within the market segment - Miscellaneous oncology
Fortress Biotech's market capitalization in the oncology sector reflects its unique incubator business model. Its size isn't based on a single drug, but rather on a diversified portfolio of multiple biotech projects, making its share a proxy for the health of an entire innovation cluster.
Market capitalization of the market segment - Miscellaneous oncology
Fortress Biotech is an incubator developing numerous oncology projects. To understand the scale of the field where it's sowing its seeds, take a look at the chart below—it's a summary assessment of the entire biotech sector. Its dynamics reflect investors' appetite for risk and the search for the next blockbuster.
Market capitalization of all companies included in a broad market index - GURU.Markets
Fortress Biotech is a unique biotech holding that invests in and develops a portfolio of several subsidiaries, each working on its own drug. Its market capitalization is the sum of its bets on the success of these various projects. The chart below shows the weightings of these diversified investors.
Book value capitalization of the company, segment and market as a whole
FBIO - Book value capitalization of the company Fortress Biotech Inc.
Fortress Biotech's book value is the capital it invests in its portfolio of biotech companies. The chart below shows not its production assets, but the financial foundation of its unique business model. Its growth reflects its successful fundraising to finance promising developments.
FBIO - Share of the company's book capitalization Fortress Biotech Inc. within the market segment - Miscellaneous oncology
Fortress Biotech is a unique company that acquires and develops promising drugs. Its physical assets include a network of laboratories and subsidiaries. The chart below shows how this diversified asset base supports its strategy to develop a broad portfolio of oncology drugs.
Market segment balance sheet capitalization - Miscellaneous oncology
Fortress Biotech isn't a traditional pharmaceutical company, but an incubator. Its model is relatively "lightweight," as it manages a portfolio of biotech assets rather than giant manufacturing plants. Is this structure typical for its diversified sector? The chart will show how much the industry as a whole relies on tangible assets.
Book value of all companies included in the broad market index - GURU.Markets
Fortress Biotech's assets are a diversified portfolio of stakes in several biotech companies, each developing its own drugs. Its book value reflects this unique model, where capital is spread across various scientific bets in the hopes of achieving multiple breakthroughs in cancer treatment.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Fortress Biotech Inc.
Fortress Biotech operates as a biotech venture capital fund: it acquires and develops promising drugs. Its balance sheet reflects these investments, but the market evaluates its ability to select future "winners" and bring them to commercialization. The chart shows how investors value this portfolio of biotech hopefuls and the competencies of its team.
Market to book capitalization ratio in a market segment - Miscellaneous oncology
Fortress Biotech operates as an incubator for biotech startups. Its book value may not reflect the full potential of its portfolio of companies. This chart shows the market's confidence in Fortress's ability to identify and develop successful projects. This is a valuation of its venture capital model, not just its existing assets.
Market to book capitalization ratio for the market as a whole
Fortress Biotech operates using a unique model, acquiring and developing promising pharmaceutical developments. This chart shows how the market values its diversified portfolio of biotech "bets." The company's value stems not so much from its own laboratories as from the potential of a wide range of drug candidates at various stages of development.
Debts of the company, segment and market as a whole
FBIO - Company debts Fortress Biotech Inc.
Fortress Biotech manages a diversified portfolio of biotech assets, requiring a flexible approach to funding multiple R&D programs. Debt is a strategic tool for the company, allowing it to acquire promising developments and support clinical trials at its subsidiaries. This chart illustrates how the company allocates capital across its broad portfolio.
Market segment debts - Miscellaneous oncology
Fortress Biotech operates under a unique business model, creating and developing a portfolio of several biotech companies. This diversifies the risks inherent in pharmaceutical development. The chart reflects financial standards for the biotech sector, allowing one to assess how Fortress's capital management strategy within its startup ecosystem aligns with industry norms.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Fortress Biotech Inc.
Fortress Biotech operates as an incubator, managing the development pipeline of several biotech companies. This chart helps illustrate how aggressively Fortress uses debt financing to support its subsidiary projects. High debt levels can accelerate the development of promising drugs, but they also increase financial risks for the entire entity.
Market segment debt to market segment book capitalization - Miscellaneous oncology
Biotech holdings like Fortress invest in a portfolio of several development companies, diversifying risk. This chart shows the overall debt burden in the sector. It allows us to assess how Fortress's financial strategy, which manages multiple projects at various stages, differs from that of focused biotech companies with one or two drugs.
Debt to book value of all companies in the market
Fortress Biotech operates as an incubator for biotech startups, managing a portfolio of developments. This diversified model requires flexible financing, including debt. This chart shows how its unique capital structure and debt obligations compare to the aggregate stock market.
P/E of the company, segment and market as a whole
P/E - Fortress Biotech Inc.
This chart shows the valuation of Fortress Biotech, a biotech incubator. For a holding company with a diversified development portfolio, this metric reflects investors' overall confidence in the success of its numerous projects. It helps understand how the market evaluates the company's ability to select promising drugs and bring them to commercialization.
P/E of the market segment - Miscellaneous oncology
This chart shows the average valuation for biotech holdings similar to Fortress Biotech. This metric helps understand how the market as a whole values the business model of an incubator investing in a portfolio of developments. It provides a benchmark for understanding whether the market rewards Fortress for its risk diversification.
P/E of the market as a whole
Fortress Biotech operates as a business incubator, developing and funding a portfolio of several biotech companies. Its valuation is the sum of the expected success of many different drugs. This chart shows the overall market appetite for risk. It allows one to assess whether Fortress's diversified model benefits from general optimism in biotech or whether its value depends on breakthroughs in specific projects.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Fortress Biotech Inc.
Fortress Biotech operates under a unique business model, building and funding a portfolio of multiple biotech partners. Its future success depends on the clinical trial results of this diversified portfolio. This chart shows how investors assess the overall probability of success across the company's entire pipeline of oncology and other developments, rather than focusing on a single drug.
%20P%2FE%20Fortress%20Biotech%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Fortress-Biotech-Inc.&v=1772607245711 "Chart of the company's future (projected) P/E Fortress Biotech Inc.")
Future (projected) P/E of the market segment - Miscellaneous oncology
Fortress Biotech operates under a unique model: it not only develops its own drugs but also acquires and develops promising assets from other biotech companies. It is a kind of diversified biotech holding. The chart shows average expectations for the sector, allowing one to assess how the market views Fortress Biotech's portfolio strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Miscellaneous-oncology&v=1772607245742 "Future (projected) P/E graph of the market segment - Miscellaneous oncology")
Future (projected) P/E of the market as a whole
Fortress Biotech operates under an incubator model, developing a portfolio of multiple biotech companies. This market expectations chart reflects overall risk appetite. During periods of optimism, investors are more willing to invest in innovative but risky startups, allowing Fortress to more easily raise funding for its subsidiaries and increasing their overall valuation.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772607245768 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Fortress Biotech Inc.
Fortress Biotech operates under an incubator model, acquiring and developing promising pharmaceutical assets. This chart shows the financial performance of a diversified but high-risk portfolio. Profits may be variable and depend on successful trial stages, licensing agreements, or the sale of a subsidiary.
Profit of companies in the market segment - Miscellaneous oncology
Mogo Inc. is a Canadian fintech company offering a range of digital financial products, from loans to cryptocurrency trading. Profitability in this highly competitive sector depends on customer acquisition costs and customer lifetime value. This chart shows how fintech platforms compete for market share, balancing rapid growth with achieving sustainable profitability.
Overall market profit
Fortress Biotech is a biotech company with a diversified business model, developing a portfolio of several subsidiaries with different drug pipelines. This allows it to spread risks. Fortress's performance reflects the overall health of the biotech sector and its ability to identify and finance promising research projects.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Fortress Biotech Inc.
Fortress Biotech operates under a unique business incubator model, developing and funding a portfolio of several biotech partner companies. Its revenue forecast depends on the success of these subsidiaries in clinical trials and commercialization. This chart shows analyst expectations for Fortress's entire diversified oncology pipeline.
%20profit%20of%20the%20company%20Fortress%20Biotech%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Fortress-Biotech-Inc.&v=1772607245908 "Graph of future (projected) profit of the company Fortress Biotech Inc.")
Future (predicted) profit of companies in the market segment - Miscellaneous oncology
Fortress Biotech operates under an incubator model, developing a portfolio of multiple biotech startups in various oncology fields. This strategy diversifies risk in a high-risk industry. This chart shows overall profitability forecasts for the entire sector. It helps understand how successful Fortress's model is in creating value, given overall biotech trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Miscellaneous-oncology&v=1772607245989 "Graph of future (predicted) profits of companies in a market segment - Miscellaneous oncology")
Future (predicted) profit of the market as a whole
Fortress Biotech operates as an incubator for oncology startups, diversifying risks across multiple projects. The presented graph of aggregate market profit expectations helps understand the overall economic backdrop. For Fortress, this determines not only the cost of capital for new research but also the potential appetite of large pharmaceutical companies for acquisitions.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772607246019 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Fortress Biotech Inc.
Fortress Biotech operates under a unique business model, creating and funding a portfolio of subsidiary biotech companies, each developing its own drug. Its revenue is generated from a variety of sources, including royalties and licensing fees. This chart shows how the market views this diversified approach to biotech and drug development investments.
P/S market segment - Miscellaneous oncology
Fortress Biotech is a biopharmaceutical holding company that develops and commercializes a portfolio of drugs through subsidiaries, focusing on oncology. The company's model diversifies risks and revenue sources. This chart reflects the industry average valuation, helping investors understand how the market views Fortress's diversified business model within the sector.
P/S of the market as a whole
Fortress Biotech manages a diversified portfolio of biotech assets, spreading risk across several promising developments. Its revenue can be volatile and depends on success in various therapeutic areas. This chart provides a snapshot of market valuations, helping investors understand how the market views the complex model of this biotech incubator.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Fortress Biotech Inc.
Fortress Biotech operates under the business incubator model, developing a portfolio of several biotech companies. This chart shows how investors assess the combined future potential of all its assets. This trend reflects the market's confidence in Fortress's ability to successfully advance various drugs through clinical trials and ultimately bring them to market.
%20P%2FS%20Fortress%20Biotech%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Fortress-Biotech-Inc.&v=1772607246224 "The graph of the company's future (projected) P/S Fortress Biotech Inc.")
Future (projected) P/S of the market segment - Miscellaneous oncology
Fortress Biotech operates using a unique model, building a portfolio of biotech companies to develop and commercialize promising drugs. Its success depends on the careful selection of assets. This chart shows how investors evaluate the combined future sales potential of its subsidiaries compared to other biotech players, reflecting confidence in its business strategy.
%20P%2FS%20market%20segment%20graph%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Miscellaneous-oncology&v=1772607246276 "Future (projected) P/S market segment graph - Miscellaneous oncology")
Future (projected) P/S of the market as a whole
This chart reflects the market's faith in innovative approaches to drug development. Fortress Biotech operates under a business incubator model, developing a portfolio of multiple biotech partners. This diversified approach to finding new treatments for cancer and other diseases allows investors to focus on the entire platform rather than a single drug.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772607246381 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Fortress Biotech Inc.
Fortress Biotech operates under a unique business model, developing a portfolio of biotech companies. Its revenue is generated from several streams: sales of commercialized drugs and income from licensing agreements and partnerships within its ecosystem. This chart shows how its diversified approach to drug development translates into overall cash flow.
Sales of companies in the market segment - Miscellaneous oncology
Fortress Biotech uses a unique business model, acting as an incubator for promising oncology drugs. The company creates and funds subsidiaries to develop various therapies. The data presented shows the overall size of the entire oncology market. Fortress's strategy allows it to target multiple niches within this vast cash flow.
Overall market sales
Fortress Biotech is an incubator company that acquires and develops promising early-stage pharmaceutical assets. Its diversified portfolio focuses on various oncology and rare diseases. This graph of the overall economic situation influences the availability of venture capital and IPO market sentiment, which are critical to Fortress's business model.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Fortress Biotech Inc.
Fortress Biotech is a biopharmaceutical company with a diversified pipeline of developments in oncology and rare diseases. Its model is based on the acquisition and development of promising assets. This chart shows analyst revenue forecasts, which reflect their combined expectations for multiple clinical programs and potential commercial launches.
%20sales%20of%20the%20company%20Fortress%20Biotech%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Fortress-Biotech-Inc.&v=1772607246600 "Schedule of future (projected) sales of the company Fortress Biotech Inc.")
Future (projected) sales of companies in the market segment - Miscellaneous oncology
Fortress Biotech operates using a unique model, acquiring and developing a portfolio of promising oncology drugs through its subsidiaries. This diversified approach mitigates risk. This chart shows projected revenue for the entire oncology segment, providing insight into overall market expectations and growth potential for the industry as a whole.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Miscellaneous-oncology&v=1772607246683 "Schedule of future (projected) sales of companies in the market segment - Miscellaneous oncology")
Future (projected) sales of the market as a whole
Fortress Biotech manages a diversified portfolio of biotech assets, developing various therapeutics. The company's business model is based on raising capital to fund clinical trials. This chart reflects the overall economic situation, which shapes investor sentiment and their willingness to invest in long-term scientific projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772607246713 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Fortress Biotech Inc.
Fortress Biotech operates under an incubator model, developing a portfolio of biotech companies. This chart demonstrates the overall financial performance of this strategy. It reflects how successfully the holding company converts revenue from partnerships, licensing, and asset sales into net profit while managing risks and costs across multiple R&D projects simultaneously.
Market segment marginality - Miscellaneous oncology
Fortress Biotech develops a diversified portfolio of biotech assets. This model requires strict cost control for each project. The data presented helps us understand how effectively the company manages its complex structure and allocates capital compared to the biotech industry average.
Market marginality as a whole
Fortress Biotech is a unique company that invests in and develops a portfolio of several biotech startups working in various areas of oncology. Their business model diversifies the risk of clinical failure. The presented overall profitability chart influences them through investors' assessment of the entire biotech sector and their willingness to fund new developments.
Employees in the company, segment and market as a whole
Number of employees in the company Fortress Biotech Inc.
Fortress Biotech operates under a unique model, acquiring and developing promising drugs through its subsidiaries. This chart reflects the size of the central management team that oversees a diversified portfolio of biotech assets. Growth here signifies portfolio expansion and increased operational activity across the holding company.
Share of the company's employees Fortress Biotech Inc. within the market segment - Miscellaneous oncology
Fortress Biotech is a unique business model that develops a portfolio of biotech companies. This indicator aggregates the talent pool of its numerous partners, demonstrating Fortress's collective strength as a talent magnet in various fields of oncology and rare diseases.
Number of employees in the market segment - Miscellaneous oncology
Fortress Biotech, Inc. operates under a unique business model, creating and funding a portfolio of several biotech companies, each focused on a distinct therapeutic area. This chart shows the company's overall oncology activities. It illustrates the broad scope of activities across which Fortress is diversifying its bets in pursuit of breakthrough cancer treatments.
Number of employees in the market as a whole
Fortress Biotech operates as a biotech incubator, developing and commercializing a diverse portfolio of drugs. Its model requires a wide range of specialists, from researchers to marketers. This chart illustrates the overall labor market, where such companies create jobs across the entire value chain, from scientific idea to the final product for patients.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Fortress Biotech Inc. (FBIO)
Fortress Biotech is an incubator for biotech startups developing a broad portfolio of drugs. This valuation per employee reflects the unique business model: a small core team manages multiple projects. A high valuation suggests that the market values the potential of the entire portfolio, not just the performance of the head office.
%20of%20the%20company%20Fortress%20Biotech%20Inc.%20(FBIO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Fortress-Biotech-Inc.-FBIO&v=1772607247198 "Chart of market capitalization per employee (in thousands of dollars) of the company Fortress Biotech Inc. (FBIO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Miscellaneous oncology
Fortress Biotech operates under a unique business model, developing its oncology drug portfolio through partnerships and acquisitions. This metric helps assess how effectively its management team creates value. Its high market capitalization per employee reflects not production capacity, but the value of its managed assets and the commercial potential of the entire portfolio.
%20by%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Miscellaneous-oncology&v=1772607247208 "Market capitalization per employee (in thousands of dollars) by market segment - Miscellaneous oncology")
Market capitalization per employee (in thousands of dollars) for the overall market
Fortress Biotech manages a portfolio of several biotech companies. Its model diversifies the risks inherent in pharmaceutical development. Its per-employee valuation reflects not individual products, but the ability of a small, central team to manage capital and identify promising research projects, creating value through a portfolio approach.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772607247254 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Fortress Biotech Inc. (FBIO)
Fortress Biotech is a holding company with a unique model. They don't just conduct R&D; they acquire and finance a portfolio of several biotech startups. This metric reflects the efficiency of their corporate structure: it shows how much net profit (or loss) is generated by the small central staff managing this diversified portfolio of R&D assets.
%20Chart%20Fortress%20Biotech%20Inc.%20(FBIO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Fortress-Biotech-Inc.-FBIO&v=1772607247269 "Company Profit Per Employee (in thousands of dollars) Chart Fortress Biotech Inc. (FBIO)")
Profit per employee (in thousands of dollars) in the market segment - Miscellaneous oncology
Fortress Biotech operates under an incubator model, developing a portfolio of biotech companies. This metric is an average across all projects. The graph reflects the industry benchmark, and FBIO's goal is to ensure that the success of several portfolio companies offsets the costs of the others, ensuring overall staff efficiency above the industry average through diversification.
%20in%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Miscellaneous-oncology&v=1772607247303 "Chart of profit per employee (in thousands of dollars) in the market segment - Miscellaneous oncology")
Profit per employee (in thousands of dollars) for the market as a whole
Fortress Biotech (FBIO) manages a portfolio of biotech companies. Instead of focusing solely on a single bet, they diversify their exposure to oncology. This metric demonstrates how effectively their relatively small corporate staff converts their subsidiaries' research and development into profits. It's an indicator of the effectiveness of their incubator business model.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772607247371 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Fortress Biotech Inc. (FBIO)
Fortress Biotech operates under the business incubator model for biotech startups. This chart shows how successfully the core team manages its development pipeline. The growth in revenue per employee reflects the commercialization of subsidiary companies' drugs and royalty income.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Fortress-Biotech-Inc.-FBIO&v=1772607247412 "Sales chart per company employee Fortress Biotech Inc. (FBIO)")
Sales per employee in the market segment - Miscellaneous oncology
Fortress Biotech is a holding company managing a portfolio of biotech startups in the oncology field. Their model is focused on identifying, funding, and developing R&D projects. This chart shows the average revenue per employee by segment. This chart allows you to evaluate how effectively Fortress, the parent company, monetizes its portfolio and manages its staff compared to other biotech firms.
Sales per employee for the market as a whole
Fortress Biotech (FBIO) uses a unique "incubator" business model, managing a portfolio of several oncology startups. This chart shows how effectively their centralized management team generates revenue (through partner fees and royalties from portfolio companies) per employee. An increase in this indicator indicates successful asset commercialization.
Short shares by company, segment and market as a whole
Shares shorted by company Fortress Biotech Inc. (FBIO)
Fortress Biotech is a holding company managing a portfolio of several biotech startups. Its model diversifies risks but also requires constant capital to fund its multiple programs. This chart reflects investor skepticism regarding this complex structure, its high cash burn rate, and the likelihood of success for its numerous subsidiaries.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Fortress-Biotech-Inc.-FBIO&v=1772607247547 "Short Shares Chart for the Company Fortress Biotech Inc. (FBIO)")
Shares shorted by market segment - Miscellaneous oncology
Fortress Biotech (FBIO) operates as a holding company, developing a diversified portfolio of drugs, primarily in oncology, through its subsidiaries. This indicator summarizes short positions in the biotech sector. It demonstrates the extent to which investors generally doubt the sustainability of a business model based on the development of multiple early-stage and risky assets.
Shares shorted by the overall market
Fortress Biotech (FBIO) is a holding company that manages a portfolio of biotech startups. When this fear indicator rises, investors flee complexity. They don't want to analyze FBIO's portfolio, viewing it as "double risk" (both the biotech and the holding company) and selling it, fearing cascading funding problems.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Fortress Biotech Inc. (FBIO)
Fortress Biotech is an atypical biotech company. It's a holding company that finances and develops a portfolio of multiple startups. Their stock is a bet on their ability to pick winners. This chart measures how investors value this risky portfolio, showing peaks of optimism (overbought) and troughs (oversold).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Fortress-Biotech-Inc.-FBIO&v=1772607247703 "RSI 14 indicator chart for the company's stock Fortress Biotech Inc. (FBIO)")
RSI 14 Market Segment - Miscellaneous oncology
Fortress (FBIO) is a biotech "incubator." They don't "dig," but rather create and finance a portfolio of subsidiaries (like Mustang Bio and Checkpoint) based on "foreign" science. The "Miscellaneous Oncology" (biotech) sector thrives on news. RSI_14_Seg shows the "temperature" of this entire segment. It's vital to understand: is FBIO's growth driven by their portfolio, or is the entire biotech sector "overheated"?
RSI 14 for the overall market
Fortress Biotech (FBIO) is a biotech holding company. This chart is an indicator of R&D health. In the euphoria of biotech (FBIO's portfolio), funding is generous and hundreds of clinical trials are launched. In a panic, R&D funding freezes, the number of trials drops, and the entire holding company model comes under pressure.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast FBIO (Fortress Biotech Inc.)
Fortress Biotech is a biotech holding company managing a portfolio of subsidiaries with various drugs in development. This chart shows the average analyst forecast. The estimates are based on the sum-of-the-parts (SOTP) method, where analysts assess the likelihood of success for each asset in Fortress's portfolio.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-FBIO-Fortress-Biotech-Inc.&v=1772607247911 "A chart showing analyst consensus forecasts for the expected stock price. FBIO (Fortress Biotech Inc.)")
The difference between the consensus estimate and the actual stock price FBIO (Fortress Biotech Inc.)
Fortress Biotech is not a classic biotech company, but a holding company. The company finances and manages a portfolio of dozens of startups with various drugs. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their "aggregate" valuation of this diversified R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-FBIO-Fortress-Biotech-Inc.&v=1772607248034 "A chart showing the difference between the consensus forecast and the actual stock price. FBIO (Fortress Biotech Inc.)")
Analyst consensus forecast for stock prices by market segment - Miscellaneous oncology
Fortress Biotech is a "biotech incubator." The company doesn't have a single product, but rather manages a portfolio of dozens of R&D startups, diversifying risks. This chart reflects general expectations for the oncology sector. It shows whether experts believe in this "venture" model for public biotech.
Analysts' consensus forecast for the overall market share price
Fortress Biotech (FBIO) is a biotech incubator. They don't conduct R&D themselves, but manage a portfolio of subsidiaries, each of which develops its own drug (primarily for cancer). This chart shows the overall risk appetite of Fortress Biotech. It reflects the market's willingness to invest in complex holding structures in the riskiest sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Fortress Biotech Inc.
Fortress Biotech is a biotech incubator. They don't have a single lab; their business is identifying, funding, and managing a portfolio of dozens of R&D startups (subsidiaries), each with its own drug. This chart is a summary indicator of their portfolio strategy. It reflects their ability to select winners, their complex finances, and their reliance on exits (subsidiary sales).
AKIMA Market Segment Index - Miscellaneous oncology
Fortress Biotech is a biotech holding company that manages a portfolio of several startups developing various drugs (primarily in oncology). This chart shows the average index for the oncology sector. It allows one to assess how Fortress's diversified portfolio model compares to the average.
The AKIM Index for the overall market
Fortress Biotech is a company that acquires, develops, and commercializes pharmaceutical products through its subsidiaries. This is a "portfolio" model. This chart, reflecting the market average, provides a macro backdrop. It helps assess how Fortress Biotech, which depends on the success of many smaller biotechs, compares to overall economic trends.
